Drug-induced subacute cutaneous lupus erythematosus.
Subacute cutaneous lupus erythematosus (SCLE) is a subset of cutaneous lupus erythematosus with unique immunologic and clinical features. The first description dates back to 1985 when a series of five patients were found to have hydrochlorothiazide-induced SCLE. Since that time, at least 40 other drugs have been implicated in the induction of SCLE.
Callen
J P
JP
Division of Dermatology, Department of Medicine, University of Louisville School of Medicine, Louisville, KY, USA. jefca@aol.com
D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D010787:Photosensitivity Disorders / Q000139:chemically induced; D012867:Skin / Q000473:pathology*
D006852:Hydrochlorothiazide